Digital Psychiatry

Latest News

Our new column on AI in psychiatry explores the future of mental health care.
Join the Conversation: Introducing “Chatbot Corner”

February 5th 2024

AI is evolving and changing the landscape of medicine and psychiatry. Here’s how clinicians can understand AI’s potential for psychiatry as well as its limitations.
AI in Psychiatry: Things Are Moving Fast

January 12th 2024

The device is now available at 2 US clinics, with training and installation currently underway at several other locations.
First FDA-Approved Self-Neuromodulation Device for PTSD Officially Launches in the US

January 4th 2024

Here are highlights from some of the year’s top features in Psychiatric Times from throughout 2023.
The Year in Cover Stories 2023

December 27th 2023

Latest CME Events & Activities

The Expanding Role of Fluid Biomarkers in the Diagnosis and Management of Patients With Alzheimer Disease

View More

Clinical Consultations™: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis

View More

Expert Illustrations & Commentaries™: Visualizing New Therapeutic Targets in Schizophrenia

View More

Advances In™ Schizophrenia: Expanding the Therapeutic Landscape

View More

Southern California Psychiatry Conference

September 13-14, 2024

Register Now!

Updates on New and Emerging Therapies to Improve Outcomes for Patients With Major Depressive Disorder

View More

5th Annual International Congress on the Future of Neurology®

View More

2023 Annual Psychiatric Times™ World CME Conference

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

More News

© 2024 MJH Life Sciences

All rights reserved.